Culanag Jr, Francisco T.
HRN: 23-06-90 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2023
MEBENDAZOLE 500MG (TAB)
05/22/2023
05/22/2023
PO
500mg
SD
T/C Ascariasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes